ABC control of diabetes: Survey data from National Diabetes Health Promotion Centers in Taiwan

Diabetes Research and Clinical Practice

Volumn 84, Issue 2, 2009, Pages 194-200

  Yu, Neng Chun ^a   Su, Hsiu Yueh ^b   Tsai, Shih Tzer ^c   Lin, Boniface J ^d   Shiu, Ruei Shiang ^e   Hsieh, Yu Chuan ^e   Sheu, Wayne Huey Herng ^f,g,h  

^a Yu Neng Chun Diabetes Clinic   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

^e DEPARTMENT OF HEALTH   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

ABC goals; Blood pressure; Cholesterol; Diabetes; HbA1c

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE;

AGED; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; HEALTH PROMOTION; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE; REGRESSION ANALYSIS; SMOKING; TAIWAN; TREATMENT OUTCOME;

EID: 63749113300     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.02.020     Document Type: Article

References (35)

1. Alberti K.G., Zimmet P., and Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet. Med. 24 (2007) 451-463
2. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 6 (2003) 917-932
3. Gu K., Cowie C.C., and Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 14 (1999) 1291-1297
4. Tseng C.H., Tseng C.P., Chong C.K., Huang T.P., Song Y.M., Chou C.W., et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49 (2006) 1755-1760
5. (Accessed 10.10.07).
6. American Diabetes Association, Standards of medical care in diabetes-2007, Diabetes Care 30 (2007) S4-S41.
7. Tai T.Y., Chuang L.M., Tsai S.T., and Huang B.Y. Treatment of type 2 diabetes mellitus in a primary care setting in Taiwan: comparison with secondary/tertiary care. J. Formos. Med. Assoc. 105 (2006) 105-117
8. Charpentier G., Genes N., Vaur L., Amar J., Clerson P., Cambou J.P., et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab. 29 (2003) 152-158
9. Fan T., Koro C.E., Fedder D.O., and Bowlin S.J. Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002. Diabetes Care 29 (2006) 1924-1925
10. Orozco Beltran D., Gil Guillen V.F., Quirce F., Navarro Perez J., Pineda M., Gomez de la Camara A., et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Int. J. Clin. Prac. 61 (2007) 909-915
11. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 21 (2004) 335-342
12. Varma S., Boyle L.L., Varma M.R., and Patt G.A. Controlling the ABCs of diabetes in clinical practice: a community-based endocrinology practice experience. Diabetes Res. Clin. Pract. 80 (2008) 89-95
13. http://www.labmed.org.tw/member/PDF (accessed Jan 30, 2009).
14. Fox C.S., Coady S., Sorlie P.D., D'Agostino Sr. R.B., Pencina M.J., Vasan R.S., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 27 (2007) 1544-1550
15. Tai T. Current status of diabetes in Taiwan. Diabetes Res. Clin. Pract. 50 (2000) S1-S2
16. Tseng C.H. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care 27 (2004) 1605-1609
17. Wu M.S., Wu M.C., Lee W.J., Tschen S.M., Lin S.Y., Lee I.T., et al. Predictors of mortality in hospitalized diabetic patients: a 7-year prospective study. Diabetes Res. Clin. Pract. 80 (2008) 449-454
18. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
19. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
20. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 8 (1998) 837-853
21. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 21 (2003) 2560-2572
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 16 (2001) 2486-2497
23. IDF West Pacific Region. Type 2 diabetes: Practice target and treatment. 4th ed. (Accessed 10.10.07).
24. (Accessed 15.01.08).
25. Resnick H.E., Foster G.L., Bardsley J., and Ratner R.E. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29 (2006) 531-537
26. Clark Jr. C.M., Fradkin J.E., Hiss R.G., Lorenz R.A., Vinicor F., and Warren Boulton E. The National Diabetes Education Program. Changing the way diabetes is treated: comprehensive diabetes care. Diabetes Care 24 (2001) 617-618
27. Fleming B.B., Greenfield S., Engelgau M.M., Pogach L.M., Clauser S.B., and Parrott M.A. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24 (2001) 1815-1820
28. Dormandy J.A., Charbonnel B., Eckland D.J., Erdmann E., Massi Benedetti M., Moules I.K., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROACTIVE Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 8 (2005) 1279-1289
29. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 14 (2007) 2457-2471
30. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 31 (2008) 173-175
31. Tseng F.Y., Lai M.S., Syu C.Y., and Lin C.C. Professional accountability for diabetes care in Taiwan. Diabetes Res. Clin. Pract. 71 (2006) 192-201
32. Chen H.F., Ho C.A., and Li C.Y. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 29 (2006) 2409-2414
33. Chuang L.M., Tsai S.T., Huang B.Y., and Tai T.Y. The current state of diabetes management in Taiwan. Diabetes Res. Clin. Pract. 54 (2001) S55-S65
34. Fenton J.J., Von Korff M., Lin E.H., Ciechanowski P., and Young B.A. Quality of preventive care for diabetes: effects of visit frequency and competing demands. Ann. Fam. Med. 4 (2006) 32-39
35. Weng R.H., Shiu R.S., and Hsieh Y.C. Current status of diabetes shared care in Taiwan. Formos. J. Med. 6 (2002) 569-573